Possible Therapies for Hepatocellular Carcinoma-Preparing for the Modern War with the Insidious Enemy

Int J Mol Sci. 2023 Aug 8;24(16):12536. doi: 10.3390/ijms241612536.

Abstract

Hepatocellular carcinoma (HCC) accounts for 7% of all malignancies and about 90% of all primary liver malignancies, making it the most common type of malignant liver neoplasm [...].

Publication types

  • Editorial

MeSH terms

  • Carcinoma, Hepatocellular* / therapy
  • Humans
  • Liver Neoplasms* / therapy

Grants and funding

This work received no external funding.